Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Durrant

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Internal Medicine Journal|March 23, 2022
Activity and outcomes of autologous stem cell transplantation in the private sector in AustraliaKarthik Nath, Yvette James, Debra Taylor, et al.
Blood Cancer Journal|December 16, 2017
Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experienceHeshani Mediwake, Cameron Curley, Jason Butler, et al.
Journal of Sleep Research|March 18, 2025
Response to Martin-Olalla and Mira's Letter to the Editor 'Seasonal Daylight Saving Time in UK: A Long-Standing, Successful Record With Few Reasons to Alter'Megan R Crawford, Eva C Winnebeck, Malcolm von Schantz, et al.
British Journal of Haematology|August 7, 2012
A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myelomaWilliam Bensinger, Richard T Maziarz, Sundar Jagannath, et al.
Journal of Sleep Research|October 23, 2024
The British Sleep Society position statement on Daylight Saving Time in the UKMegan R Crawford, Eva C Winnebeck, Malcolm von Schantz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSFGeoffrey R Hill, Edward S Morris, Madonna Fuery, et al.
Leukemia & Lymphoma|November 17, 2006
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphomaMax Wolf, Mark Bentley, Paula Marlton, et al.
Annals of Hematology|February 4, 2018
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studiesJean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, et al.
Blood|December 19, 2013
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitorsHagop M Kantarjian, Jorge E Cortes, Dong-Wook Kim, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin BFritz Offner, Vladimir Krcmery, Marc Boogaerts, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Internal Medicine Journal|March 23, 2022
Activity and outcomes of autologous stem cell transplantation in the private sector in AustraliaKarthik Nath, Yvette James, Debra Taylor, et al.
Blood Cancer Journal|December 16, 2017
Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experienceHeshani Mediwake, Cameron Curley, Jason Butler, et al.
Journal of Sleep Research|March 18, 2025
Response to Martin-Olalla and Mira's Letter to the Editor 'Seasonal Daylight Saving Time in UK: A Long-Standing, Successful Record With Few Reasons to Alter'Megan R Crawford, Eva C Winnebeck, Malcolm von Schantz, et al.
British Journal of Haematology|August 7, 2012
A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myelomaWilliam Bensinger, Richard T Maziarz, Sundar Jagannath, et al.
Journal of Sleep Research|October 23, 2024
The British Sleep Society position statement on Daylight Saving Time in the UKMegan R Crawford, Eva C Winnebeck, Malcolm von Schantz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSFGeoffrey R Hill, Edward S Morris, Madonna Fuery, et al.
Leukemia & Lymphoma|November 17, 2006
Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphomaMax Wolf, Mark Bentley, Paula Marlton, et al.
Annals of Hematology|February 4, 2018
Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studiesJean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, et al.
Blood|December 19, 2013
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitorsHagop M Kantarjian, Jorge E Cortes, Dong-Wook Kim, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin BFritz Offner, Vladimir Krcmery, Marc Boogaerts, et al.
Pageof 6